These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
406 related articles for article (PubMed ID: 24243499)
41. Recent advances in neuropathology, biomarkers and therapeutic approach of multiple system atrophy. Koga S; Dickson DW J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):175-184. PubMed ID: 28860330 [TBL] [Abstract][Full Text] [Related]
42. Binding of neuronal α-synuclein to β-III tubulin and accumulation in a model of multiple system atrophy. Nakayama K; Suzuki Y; Yazawa I Biochem Biophys Res Commun; 2012 Jan; 417(4):1170-5. PubMed ID: 22227187 [TBL] [Abstract][Full Text] [Related]
43. Bladder dysfunction in a transgenic mouse model of multiple system atrophy. Boudes M; Uvin P; Pinto S; Voets T; Fowler CJ; Wenning GK; De Ridder D; Stefanova N Mov Disord; 2013 Mar; 28(3):347-55. PubMed ID: 23426727 [TBL] [Abstract][Full Text] [Related]
44. Immunohistochemical and biochemical studies demonstrate a distinct profile of alpha-synuclein permutations in multiple system atrophy. Duda JE; Giasson BI; Gur TL; Montine TJ; Robertson D; Biaggioni I; Hurtig HI; Stern MB; Gollomp SM; Grossman M; Lee VM; Trojanowski JQ J Neuropathol Exp Neurol; 2000 Sep; 59(9):830-41. PubMed ID: 11005264 [TBL] [Abstract][Full Text] [Related]
45. Failure of Neuroprotection Despite Microglial Suppression by Delayed-Start Myeloperoxidase Inhibition in a Model of Advanced Multiple System Atrophy: Clinical Implications. Kaindlstorfer C; Sommer P; Georgievska B; Mather RJ; Kugler AR; Poewe W; Wenning GK; Stefanova N Neurotox Res; 2015 Oct; 28(3):185-94. PubMed ID: 26194617 [TBL] [Abstract][Full Text] [Related]
46. Immunohistochemical localization of aggresomal proteins in glial cytoplasmic inclusions in multiple system atrophy. Chiba Y; Takei S; Kawamura N; Kawaguchi Y; Sasaki K; Hasegawa-Ishii S; Furukawa A; Hosokawa M; Shimada A Neuropathol Appl Neurobiol; 2012 Oct; 38(6):559-71. PubMed ID: 22013984 [TBL] [Abstract][Full Text] [Related]
47. Grading of neuropathology in multiple system atrophy: proposal for a novel scale. Jellinger KA; Seppi K; Wenning GK Mov Disord; 2005 Aug; 20 Suppl 12():S29-36. PubMed ID: 16092088 [TBL] [Abstract][Full Text] [Related]
48. Pathological Endogenous α-Synuclein Accumulation in Oligodendrocyte Precursor Cells Potentially Induces Inclusions in Multiple System Atrophy. Kaji S; Maki T; Kinoshita H; Uemura N; Ayaki T; Kawamoto Y; Furuta T; Urushitani M; Hasegawa M; Kinoshita Y; Ono Y; Mao X; Quach TH; Iwai K; Dawson VL; Dawson TM; Takahashi R Stem Cell Reports; 2018 Feb; 10(2):356-365. PubMed ID: 29337114 [TBL] [Abstract][Full Text] [Related]
49. Breathing variability and brainstem serotonergic loss in a genetic model of multiple system atrophy. Flabeau O; Meissner WG; Ozier A; Berger P; Tison F; Fernagut PO Mov Disord; 2014 Mar; 29(3):388-95. PubMed ID: 24442757 [TBL] [Abstract][Full Text] [Related]
51. TDP-43 pathology in multiple system atrophy: colocalization of TDP-43 and α-synuclein in glial cytoplasmic inclusions. Koga S; Lin WL; Walton RL; Ross OA; Dickson DW Neuropathol Appl Neurobiol; 2018 Dec; 44(7):707-721. PubMed ID: 29660838 [TBL] [Abstract][Full Text] [Related]
52. A novel α-synuclein-GFP mouse model displays progressive motor impairment, olfactory dysfunction and accumulation of α-synuclein-GFP. Hansen C; Björklund T; Petit GH; Lundblad M; Murmu RP; Brundin P; Li JY Neurobiol Dis; 2013 Aug; 56():145-55. PubMed ID: 23643841 [TBL] [Abstract][Full Text] [Related]
57. Overexpression of α-synuclein in oligodendrocytes does not increase susceptibility to focal striatal excitotoxicity. Kuzdas-Wood D; Fellner L; Premstaller M; Borm C; Bloem B; Kirik D; Wenning GK; Stefanova N BMC Neurosci; 2015 Dec; 16():86. PubMed ID: 26627686 [TBL] [Abstract][Full Text] [Related]
58. In vivo models of multiple system atrophy. Fernagut PO; Ghorayeb I; Diguet E; Tison F Mov Disord; 2005 Aug; 20 Suppl 12():S57-63. PubMed ID: 16092092 [TBL] [Abstract][Full Text] [Related]
59. Insulin resistance and exendin-4 treatment for multiple system atrophy. Bassil F; Canron MH; Vital A; Bezard E; Li Y; Greig NH; Gulyani S; Kapogiannis D; Fernagut PO; Meissner WG Brain; 2017 May; 140(5):1420-1436. PubMed ID: 28334990 [TBL] [Abstract][Full Text] [Related]
60. Cystatin C triggers neuronal degeneration in a model of multiple system atrophy. Suzuki Y; Jin C; Yazawa I Am J Pathol; 2014 Mar; 184(3):790-9. PubMed ID: 24405769 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]